IP Law 360

AUGUST 7, 2023

million arbitral award issued to Acorda Therapeutics Inc. million to refund the company for royalties paid after the drug's patent expired. A New York federal judge has confirmed a nearly $16.6 in its dispute with Alkermes PLC over a multiple sclerosis drug, but refused to increase the award by $65.6

Patent 40

Patent 40

IP Law 360

JANUARY 11, 2023

Acorda Therapeutics Inc. has told a New York federal court that an arbitral tribunal got it wrong when it awarded the company only $16 million in a royalties dispute with an Irish pharmaceutical company, saying it's owed an additional $65 million.

40

40

Fish & Richardson Trademark & Copyright Thoughts

NOVEMBER 13, 2020

Mylan Pharmaceuticals Inc. 7] If a branded company initiates an infringement action against a generic company within 45 days of receiving notice of ANDA submission, this triggers a 30-month stay during which FDA cannot issue a final approval for the ANDA. [8] Inc. , No. Medtronic, Inc. , Mylan Pharm. 5, 2020).

Branding 52

Branding Brands Branding Litigation 52